Abstract
The benefits of hormone replacement therapy in alleviating climacteric symptoms, preventing osteoporosis and reducing the incidence of cardiovascular disease and stroke are now generally agreed. Nonetheless, perhaps only 5% of postmenopausal women currently receive adequate treatment often because of patient or clinician fears that such treatment may be associated with harmful side effects.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adult
-
Aged
-
Breast Neoplasms / chemically induced
-
Cerebrovascular Disorders / prevention & control
-
Estradiol Congeners / administration & dosage
-
Estradiol Congeners / adverse effects
-
Estradiol Congeners / therapeutic use*
-
Female
-
Genital Neoplasms, Female / chemically induced
-
Humans
-
Menopause / drug effects*
-
Middle Aged
-
Neoplasms / chemically induced*
-
Osteoporosis / prevention & control
-
Progesterone Congeners / administration & dosage
-
Progesterone Congeners / adverse effects
-
Progesterone Congeners / therapeutic use*
Substances
-
Estradiol Congeners
-
Progesterone Congeners